Edition:
United States

Livzon Pharmaceutical Group Inc (000513.SZ)

000513.SZ on Shenzhen Stock Exchange

59.42CNY
28 Apr 2017
Change (% chg)

¥-0.49 (-0.82%)
Prev Close
¥59.91
Open
¥59.91
Day's High
¥60.38
Day's Low
¥59.03
Volume
2,296,226
Avg. Vol
1,958,457
52-wk High
¥63.00
52-wk Low
¥41.45

000513.SZ

Chart for 000513.SZ

About

LIVZON PHARMACEUTICAL GROUP INC. is a China-based company principally engaged in research, development, production and distribution of pharmaceutical products. The Company primarily offers western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. The Company’s... (more)

Overall

Beta: 0.64
Market Cap(Mil.): ¥22,973.29
Shares Outstanding(Mil.): 425.60
Dividend: 0.50
Yield (%): 0.84

Financials

  000513.SZ Industry Sector
P/E (TTM): 29.12 29.08 30.08
EPS (TTM): 2.04 -- --
ROI: 15.21 13.73 13.25
ROE: 14.59 14.68 14.41

BRIEF-Livzon Pharmaceutical's Q1 net profit up 19.5 pct y/y

* Says Q1 net profit up 19.5 percent y/y at 275.0 million yuan ($39.90 million)

Apr 27 2017

BRIEF-Livzon Pharma, unit to sell pharma firm, A-share trade to resume

* Says it and unit sign agreement to sell pharma firm for 4.55 billion yuan ($660.67 million)

Apr 19 2017

BRIEF-Livzon Pharmaceutical Group says trading in H shares of company will be halted

* Trading in h shares of company will be halted pending announcement relating to proposed disposal of subsidiary Source text for Eikon: Further company coverage:

Apr 17 2017

BRIEF-Livzon Pharmaceutical's trading in A-shares to halt pending announcement

* Says trading in A-shares to halt from April 14 pending announcement related to asset sales

Apr 13 2017

BRIEF-Livzon Pharmaceutical Group sees Q1 FY 2017 net profit up 17 pct to 25 pct

* Sees Q1 FY 2017 net profit to increase by 17 percent to 25 percent, or to be 269.2 million yuan to 287.6 million yuan

Apr 12 2017

BRIEF-Livzon Pharmaceutical Group announces preliminary profit for the quarter

* Preliminary profit approximately RMB269.2 million to RMB287.6million for the quarter Source text : (http://bit.ly/2nA8mTz) Further company coverage:

Apr 11 2017

BRIEF-Livzon Pharmaceutical's 2016 net profit up 26.0 pct

* Says 2016 net profit up 26.0 percent y/y at 784.4 million yuan ($113.95 million)

Mar 24 2017

BRIEF-Livzon Pharma sees net profit up 20-30 pct in 2016

* Says it expects net profit to rise 20-30 percent y/y in 2016 at 747.2-809.4 million yuan ($117.36 million)

Jan 13 2017

More From Around the Web

Earnings vs. Estimates